Sarah Duncan, Chief Financial Officer at Circassia Pharmaceuticals, holds 5.52K shares in Circassia Pharmaceuticals (Ticker: GB:NIOX). Most recently, Sarah Duncan Bought 5,522 shares of Circassia Pharmaceuticals on Dec 04, 2025 for an estimated value of 3.90K.
What is the percentage of profitable transactions made by Sarah Duncan?
The percentage of profitable transactions made by Sarah Duncan is ―.
What is the average return per transaction made by Sarah Duncan?
The average return per transaction made by Sarah Duncan is ―.
What stocks does Sarah Duncan hold?
Sarah Duncan holds: GB:NIOX stocks.
What was Sarah Duncan’s latest transaction?
Sarah Duncan latest transaction was an Informative Buy of 3.90K.
What was Sarah Duncan's most profitable transaction?
Sarah Duncan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Sarah Duncan's role in Circassia Pharmaceuticals?
Sarah Duncan's role in Circassia Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.